Marginal Zone B-Cell Lymphoma: Causes, Signs, and Treatment

Marginal zone B-cell lymphoma is a type of cancer that originates from a specific type of white blood cell called B-cells. These abnormal B-cells accumulate in the marginal zone of the lymphoid tissues, such as the spleen, lymph nodes, and mucosa-associated lymphoid tissue (MALT). The primary impact of this lymphoma on health is the disruption of the body's immune system function. As these cancerous B-cells multiply uncontrollably, they can crowd out normal white blood cells, impairing the body's ability to fight off infections and diseases effectively.

What are the Symptoms of Marginal Zone B-Cell Lymphoma

Marginal zone B-cell lymphoma symptoms may manifest subtly, often resembling common illnesses, making diagnosis challenging without proper medical evaluation.

Fatigue
Night sweats
Swollen lymph nodes
Unexplained weight loss
Abdominal pain or discomfort
Fever
Easy bruising or bleeding

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Causes of Marginal Zone B-Cell Lymphoma

Marginal zone B-cell lymphoma may be caused by chronic infections, autoimmune diseases, or certain environmental factors.

Chronic infections
Autoimmune diseases
Sjögren syndrome
Hashimoto thyroiditis
Helicobacter pylori infection
Hepatitis C virus infection
Borrelia burgdorferi infection
Immunosuppression

Types of Marginal Zone B-Cell Lymphoma

Marginal zone B-cell lymphoma can manifest in different forms depending on the location and characteristics of the abnormal B-cells.

Extranodal Marginal Zone BCell Lymphoma: This type of lymphoma affects lymphoid tissues outside the lymph nodes, such as the stomach, lungs, or salivary glands.
Nodal Marginal Zone BCell Lymphoma: Primarily involves the lymph nodes and can also affect the spleen and bone marrow.
Splenic Marginal Zone BCell Lymphoma: Typically arises in the spleen and may involve the bone marrow and blood.
MALT Lymphoma (MucosaAssociated Lymphoid Tissue Lymphoma): Develops in areas of mucosaassociated lymphoid tissue, such as the stomach, lungs, or thyroid.
Cutaneous Marginal Zone BCell Lymphoma: Affects the skin and presents as slowgrowing lesions or nodules on the skin surface.

Risk Factors

Risk factors for Marginal zone B-cell lymphoma include chronic infections, autoimmune diseases, and certain environmental exposures, such as exposure to certain chemicals or pesticides.

Chronic infections
Autoimmune diseases
Age (typically older adults)
Gender (more common in women)
Family history of lymphoma
Exposure to certain chemicals or pesticides

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Diagnosis of Marginal Zone B-Cell Lymphoma

Marginal zone B-cell lymphoma is typically diagnosed through a series of tests and evaluations to confirm the presence of this type of cancer in the body.

Physical exam
Blood tests
Bone marrow biopsy
Imaging tests (CT scan, MRI, PET scan)
Lymph node biopsy

Treatment for Marginal Zone B-Cell Lymphoma

Marginal zone B-cell lymphoma is generally treated by a combination of therapies tailored to the individual patient's specific condition and factors.

Watchful Waiting:

Watchful waiting involves monitoring the disease progression without immediate treatment until symptoms develop or worsen.

Rituximab Therapy:

Rituximab is a monoclonal antibody that targets specific proteins on lymphoma cells, helping to destroy them and slow down disease progression.

Chemotherapy:

Chemotherapy uses drugs to kill cancer cells and is commonly used to treat Marginal zone Bcell lymphoma, either alone or in combination with other therapies.

Radiation Therapy:

Radiation therapy delivers highenergy beams to target and destroy cancer cells, often used to treat localized Marginal zone Bcell lymphoma.

Immunotherapy:

Immunotherapy boosts the body's immune system to recognize and attack cancer cells, offering a targeted approach with fewer side effects compared to traditional treatments.

Find Our Specialists